S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Rondoni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani, Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia, «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. e51 - e52 [Scientific article]
Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M., ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia, «JOURNAL OF CLINICAL ONCOLOGY», 2005, 23, pp. 4100 - 4109 [Scientific article]
Martinelli G.; Soverini S.; Rosti G.; Baccarani M., Dual tyrosine kinase inhibitors in chronic myeloid leukemia., «LEUKEMIA», 2005, 19, pp. 1872 - 1879 [Scientific article]
Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; Ottaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G, Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP., in: Abstract book, Atlanta, Georgia, 2005, 106, pp. 1100 - 1100 (atti di: 47^ American Society of Hematology Annual Meeting and Exposition, Atlanta, USA, 10-13 Dicembre 2005) [Abstract]
Martinelli G; Soverini S; Rosti G; Cilloni D; Baccarani M., New tyrosine kinase inhibitors in chronic myeloid leukemia, «HAEMATOLOGICA», 2005, 90, pp. 534 - 541 [Scientific article]
SOVERINI S; MARTINELLI G.; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M., Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib, «CLINICAL CHEMISTRY», 2004, 50, pp. 1205 - 1213 [Scientific article]
PICCALUGA PP; MALAGOLA M; RONDONI M; AMABILE M; PAOLINI S; SOVERINI S; GAITANI S; VISANI G; BACCARANI M.; MARTINELLI G, Dose increase of imatinib mesylate may overcome acquired resistance in
bcr/abl-positive acute lymphoid leukaemia, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2004, 72, pp. 302 - 303 [Scientific article]
ZINZANI P.; PULSONI A; PERROTTI A; SOVERINI S; ZAJA F; DE RENZO A; STORTI S; LAUTA VM; GUARDIGNI L; GENTILINI P; TUCCI A; MOLINARI AL; GOBBI M; FALINI B; FATTORI PP; CICCONE F; ALINARI L; MARTELLI M; PILERI S; TURA S; BACCARANI M., Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma., «JOURNAL OF CLINICAL ONCOLOGY», 2004, 22, pp. 2654 - 2661 [Scientific article]
BACCARANI M.; MARTINELLI G.; ROSTI G.; TRABACCHI E.; TESTONI N.; BASSI S.; AMABILE M.; SOVERINI S.; CASTAGNETTI F.; CILLONI D.; IZZO B.; DE VIVO A.; MESSA E.; BONIFAZI F.; POERIO A.; LUATTI S.; GIUGLIANO E.; ALBERTI D.; FINCATO G.; RUSSO D.; PANE F.; SAGLIO G.; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA, Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia, «BLOOD», 2004, 104, pp. 4245 - 4251 [Scientific article]
ROSTI G.; MARTINELLI G.; BASSI S.; AMABILE M.; TRABACCHI E.; GIANNINI B.; CILLONI D.; IZZO B.; DE VIVO A.; TESTONI N.; CAMBRIN G. R.; BONIFAZI F.; SOVERINI S.; LUATTI S.; GOTTARDI E.; ALBERTI D.; PANE F.; SALVATORE F.; SAGLIO G.; BACCARANI M.; STUDY COMMITTEE; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA ; WRITING COMMITTEE;, Molecular response to imatinib in late chronic-phase chronic myeloid leukemia, «BLOOD», 2004, 103, pp. 2284 - 2290 [Scientific article]
Martinelli G.; Buonamici S.; Visani G.; Malagola M.; Piccaluga P.P.; Isidori A.; Bosi C.; Bonifazi F.; Soverini S.; Terragna C.; Amabile M.; Giannini B.; Baccarani M.; Guerrasio A.; Pilatrino C.; Cilloni D.; Gottardi E.; Saglio G., Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8], «LEUKEMIA», 2003, 17, pp. 650 - 652 [Scientific article]
Bianchini M.; Ottaviani E.; Grafone T.; Giannini B.; Soverini S.; Terragna C.; Amabile M.; Piccaluga P.P.; Malagola M.; Rondoni M.; Bosi C.; Baccarani M.; Martinelli G., Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC, «CLINICAL CHEMISTRY», 2003, 49, pp. 1642 - 1650 [Scientific article]
Martinelli G.; Amabile M.; Giannini B.; Terragna C.; Ottaviani E.; Soverini S.; Saglio G.; Rosti G.; Baccarani M., Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia-positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24-homology domains but not the pleckstrin homology one, «HAEMATOLOGICA», 2002, 87, pp. 688 - 694 [Scientific article]
Martinelli G.; Tosi P.; Ottaviani E.; Soverini S.; Tura S., Molecular therapy for multiple myeloma, «HAEMATOLOGICA», 2001, 86, pp. 908 - 917 [Scientific article]
Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G., Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia, «HAEMATOLOGICA», 2001, 86, pp. 252 - 259 [Scientific article]
